Leal Joames K F, Adjobo-Hermans Merel J W, Bosman Giel J C G M
Department of Biochemistry, Radboud University Medical Center, Nijmegen, Netherlands.
Front Physiol. 2018 Jun 8;9:703. doi: 10.3389/fphys.2018.00703. eCollection 2018.
Red blood cells (RBCs) generate microvesicles to remove damaged cell constituents such as oxidized hemoglobin and damaged membrane constituents, and thereby prolong their lifespan. Damage to hemoglobin, in combination with altered phosphorylation of membrane proteins such as band 3, lead to a weakening of the binding between the lipid bilayer and the cytoskeleton, and thereby to membrane budding and microparticle shedding. Microvesicle generation is disturbed in patients with RBC-centered diseases, such as sickle cell disease, glucose 6-phosphate dehydrogenase deficiency, spherocytosis or malaria. A disturbance of the membrane-cytoskeleton interaction is likely to be the main underlying mechanism, as is supported by data obtained from RBCs stored in blood bank conditions. A detailed proteomic, lipidomic and immunogenic comparison of microvesicles derived from different sources is essential in the identification of the processes that trigger vesicle generation. The contribution of RBC-derived microvesicles to inflammation, thrombosis and autoimmune reactions emphasizes the need for a better understanding of the mechanisms and consequences of microvesicle generation.
红细胞(RBCs)产生微泡以清除受损的细胞成分,如氧化血红蛋白和受损的膜成分,从而延长其寿命。血红蛋白受损,再加上膜蛋白(如带3蛋白)磷酸化改变,导致脂质双层与细胞骨架之间的结合减弱,进而导致膜出芽和微粒脱落。以红细胞为中心的疾病患者,如镰状细胞病、葡萄糖6-磷酸脱氢酶缺乏症、球形红细胞增多症或疟疾,其微泡生成受到干扰。膜-细胞骨架相互作用的紊乱可能是主要的潜在机制,血库条件下储存的红细胞所获得的数据支持了这一点。对不同来源的微泡进行详细的蛋白质组学、脂质组学和免疫原性比较,对于识别触发微泡生成的过程至关重要。红细胞衍生微泡对炎症、血栓形成和自身免疫反应的作用强调了更好地理解微泡生成机制和后果的必要性。